-transparent.png){kind=logo}
Three children with stage II-III subacute sclerosing panencephalitis (SSPE) were treated with intraventricular human leukocyte interferon for 6 months. All three improved to varying degrees and for different lengths of time. Clinical remissions were associated with decreased titers of antibody to measles virus in CSF and with reduced rates of intrathecal IgG synthesis. There were no serious complications or side effects. Intraventricular interferon deserves further study as a potential therapeutic agent in SSPE.
Related Publications
H S Panitch, and
J Gomez-Plascencia, and
F H Norris, and
K Cantell, and
R A Smith
January 1989,
Journal of child neurology,
H S Panitch, and
J Gomez-Plascencia, and
F H Norris, and
K Cantell, and
R A Smith
August 1991,
Annals of neurology,
H S Panitch, and
J Gomez-Plascencia, and
F H Norris, and
K Cantell, and
R A Smith
January 1998,
Neurology,
H S Panitch, and
J Gomez-Plascencia, and
F H Norris, and
K Cantell, and
R A Smith
January 2006,
Revista de neurologia,
H S Panitch, and
J Gomez-Plascencia, and
F H Norris, and
K Cantell, and
R A Smith
June 1987,
Italian journal of neurological sciences,
H S Panitch, and
J Gomez-Plascencia, and
F H Norris, and
K Cantell, and
R A Smith
January 1989,
Brain & development,
H S Panitch, and
J Gomez-Plascencia, and
F H Norris, and
K Cantell, and
R A Smith
March 1992,
Neurology,
H S Panitch, and
J Gomez-Plascencia, and
F H Norris, and
K Cantell, and
R A Smith
December 1979,
Arquivos de neuro-psiquiatria,
H S Panitch, and
J Gomez-Plascencia, and
F H Norris, and
K Cantell, and
R A Smith
April 1994,
Italian journal of neurological sciences,
H S Panitch, and
J Gomez-Plascencia, and
F H Norris, and
K Cantell, and
R A Smith
July 1995,
Osaka city medical journal,
